# Antero Midstream Corp: financial statements, quarterly

AM · NYSE · CIK 1623925 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/am.md) · [Financials](/companies/am/financials.md) · [Filings](/companies/am/filings.md) · [Insiders](/companies/am/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/am/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [260 d](/filings/0001104659-26-013380.md) | [279](/filings/0001558370-25-006002.md) | [270](/filings/0001558370-25-009801.md) | [270](/filings/0001104659-25-103732.md) | [287 d](/filings/0001104659-26-013380.md) | [291](/filings/0001104659-26-051518.md) | [305](/filings/0001104659-26-088150.md) | [295](/filings/0001104659-26-119634.md) | [297 d](/filings/0001104659-26-013380.md) | [314](/filings/0001104659-26-051518.md) | [327](/filings/0001104659-26-088150.md) | [327](/filings/0001104659-26-119634.md) |
| Operating income | $m | [156 d](/filings/0001104659-26-013380.md) | [166](/filings/0001558370-25-006002.md) | [153](/filings/0001558370-25-009801.md) | [162](/filings/0001104659-25-103732.md) | [178 d](/filings/0001104659-26-013380.md) | [177](/filings/0001104659-26-051518.md) | [186](/filings/0001104659-26-088150.md) | [180](/filings/0001104659-26-119634.md) | [101 d](/filings/0001104659-26-013380.md) | [189](/filings/0001104659-26-051518.md) | [182](/filings/0001104659-26-088150.md) | [557](/filings/0001104659-26-119634.md) |
| Income tax | $m | [30.9 d](/filings/0001104659-26-013380.md) | [36.5](/filings/0001558370-25-006002.md) | [28.4](/filings/0001558370-25-009801.md) | [38.2](/filings/0001104659-25-103732.md) | [44.6 d](/filings/0001104659-26-013380.md) | [36.1](/filings/0001104659-26-051518.md) | [44.0](/filings/0001104659-26-088150.md) | [45.7](/filings/0001104659-26-119634.md) | [25.3 d](/filings/0001104659-26-013380.md) | [37.6](/filings/0001104659-26-051518.md) | [41.0](/filings/0001104659-26-088150.md) | [140](/filings/0001104659-26-119634.md) |
| Net income | $m | [100 d](/filings/0001104659-26-013380.md) | [104](/filings/0001104659-25-103732.md) | [86.0](/filings/0001104659-25-103732.md) | [99.7](/filings/0001104659-25-103732.md) | [111 d](/filings/0001104659-26-013380.md) | [121](/filings/0001104659-26-119634.md) | [125](/filings/0001104659-26-119634.md) | [116](/filings/0001104659-26-119634.md) | [51.9 d](/filings/0001104659-26-013380.md) | [118](/filings/0001104659-26-119634.md) | [114](/filings/0001104659-26-119634.md) | [393](/filings/0001104659-26-119634.md) |
| Diluted EPS | $ per share | not reported | [0.21](/filings/0001558370-25-006002.md) | [0.18](/filings/0001558370-25-009801.md) | [0.21](/filings/0001104659-25-103732.md) | not reported | [0.25](/filings/0001104659-26-051518.md) | [0.26](/filings/0001104659-26-088150.md) | [0.24](/filings/0001104659-26-119634.md) | not reported | [0.25](/filings/0001104659-26-051518.md) | [0.24](/filings/0001104659-26-088150.md) | [0.82](/filings/0001104659-26-119634.md) |
| Basic EPS | $ per share | not reported | [0.22](/filings/0001558370-25-006002.md) | [0.18](/filings/0001558370-25-009801.md) | [0.21](/filings/0001104659-25-103732.md) | not reported | [0.25](/filings/0001104659-26-051518.md) | [0.26](/filings/0001104659-26-088150.md) | [0.24](/filings/0001104659-26-119634.md) | not reported | [0.25](/filings/0001104659-26-051518.md) | [0.24](/filings/0001104659-26-088150.md) | [0.83](/filings/0001104659-26-119634.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001558370-25-000862.md) | [26.1](/filings/0001558370-24-005600.md) | not reported | not reported | not reported | not reported | not reported | not reported | [180](/filings/0001104659-26-119634.md) | not reported | not reported | not reported |
| Current assets | $m | [91.1](/filings/0001558370-25-000862.md) | [134](/filings/0001558370-24-005600.md) | [104](/filings/0001558370-24-010481.md) | [99.9](/filings/0001558370-24-013951.md) | [118](/filings/0001104659-26-013380.md) | [128](/filings/0001558370-25-006002.md) | [114](/filings/0001558370-25-009801.md) | [113](/filings/0001104659-25-103732.md) | [380](/filings/0001104659-26-119634.md) | [155](/filings/0001104659-26-051518.md) | [141](/filings/0001104659-26-088150.md) | [127](/filings/0001104659-26-119634.md) |
| Total assets | $m | [5,738](/filings/0001558370-25-000862.md) | [5,749](/filings/0001558370-24-005600.md) | [5,775](/filings/0001558370-24-010481.md) | [5,777](/filings/0001558370-24-013951.md) | [5,762](/filings/0001104659-26-013380.md) | [5,752](/filings/0001558370-25-006002.md) | [5,727](/filings/0001558370-25-009801.md) | [5,717](/filings/0001104659-25-103732.md) | [5,884](/filings/0001104659-26-119634.md) | [6,406](/filings/0001104659-26-051518.md) | [6,364](/filings/0001104659-26-088150.md) | [6,341](/filings/0001104659-26-119634.md) |
| Current liabilities | $m | [96.4](/filings/0001558370-25-000862.md) | [107](/filings/0001558370-24-005600.md) | [116](/filings/0001558370-24-010481.md) | [91.5](/filings/0001558370-24-013951.md) | [101](/filings/0001104659-26-013380.md) | [90.2](/filings/0001558370-25-006002.md) | [111](/filings/0001558370-25-009801.md) | [90.0](/filings/0001104659-25-103732.md) | [111](/filings/0001104659-26-119634.md) | [157](/filings/0001104659-26-051518.md) | [167](/filings/0001104659-26-088150.md) | [150](/filings/0001104659-26-119634.md) |
| Total liabilities | $m | [3,586](/filings/0001558370-25-000862.md) | [3,599](/filings/0001558370-24-005600.md) | [3,648](/filings/0001558370-24-010481.md) | [3,648](/filings/0001558370-24-013951.md) | [3,647](/filings/0001104659-26-013380.md) | [3,664](/filings/0001558370-25-006002.md) | [3,640](/filings/0001558370-25-009801.md) | [3,652](/filings/0001104659-25-103732.md) | [3,912](/filings/0001104659-26-119634.md) | [4,469](/filings/0001104659-26-051518.md) | [4,418](/filings/0001104659-26-088150.md) | [4,126](/filings/0001104659-26-119634.md) |
| Long-term debt | $m | [3,213](/filings/0001558370-25-000862.md) | [3,175](/filings/0001558370-24-005600.md) | [3,187](/filings/0001558370-24-010481.md) | [3,172](/filings/0001558370-24-013951.md) | [3,117](/filings/0001104659-26-013380.md) | [3,111](/filings/0001558370-25-006002.md) | [3,024](/filings/0001558370-25-009801.md) | [3,009](/filings/0001104659-25-103732.md) | [3,223](/filings/0001104659-26-119634.md) | [3,666](/filings/0001104659-26-051518.md) | [3,566](/filings/0001104659-26-088150.md) | [3,154](/filings/0001104659-26-119634.md) |
| Shareholders' equity | $m | [2,152](/filings/0001104659-26-013380.md) | [2,150](/filings/0001104659-25-103732.md) | [2,127](/filings/0001104659-25-103732.md) | [2,130](/filings/0001104659-25-103732.md) | [2,115](/filings/0001104659-26-119634.md) | [2,089](/filings/0001104659-26-119634.md) | [2,087](/filings/0001104659-26-119634.md) | [2,065](/filings/0001104659-26-119634.md) | [1,972](/filings/0001104659-26-119634.md) | [1,936](/filings/0001104659-26-119634.md) | [1,945](/filings/0001104659-26-119634.md) | [2,215](/filings/0001104659-26-119634.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [208 d](/filings/0001104659-26-013380.md) | [211](/filings/0001558370-25-006002.md) | [216 d](/filings/0001558370-25-009801.md) | [185 d](/filings/0001104659-25-103732.md) | [233 d](/filings/0001104659-26-013380.md) | [199](/filings/0001104659-26-051518.md) | [265 d](/filings/0001104659-26-088150.md) | [213 d](/filings/0001104659-26-119634.md) | [256 d](/filings/0001104659-26-013380.md) | [239](/filings/0001104659-26-051518.md) | [254 d](/filings/0001104659-26-088150.md) | [600 d](/filings/0001104659-26-119634.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001104659-26-013380.md) | [2.0](/filings/0001558370-25-006002.md) | [68.6 d](/filings/0001558370-25-009801.md) | [(0.6) d](/filings/0001104659-25-103732.md) | [0.0 d](/filings/0001104659-26-013380.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [108 d](/filings/0001104659-26-013380.md) | [108](/filings/0001558370-25-006002.md) | [113 d](/filings/0001558370-25-009801.md) | [109 d](/filings/0001104659-25-103732.md) | [108 d](/filings/0001104659-26-013380.md) | [113](/filings/0001104659-26-051518.md) | [112 d](/filings/0001104659-26-088150.md) | [108 d](/filings/0001104659-26-119634.md) | [107 d](/filings/0001104659-26-013380.md) | [111](/filings/0001104659-26-051518.md) | [110 d](/filings/0001104659-26-088150.md) | [107 d](/filings/0001104659-26-119634.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [28.6](/filings/0001104659-26-051518.md) | [16.8 d](/filings/0001104659-26-088150.md) | [41.3 d](/filings/0001104659-26-119634.md) | [48.3 d](/filings/0001104659-26-013380.md) | [18.0](/filings/0001104659-26-051518.md) | [8.3 d](/filings/0001104659-26-088150.md) | [27.2 d](/filings/0001104659-26-119634.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [481](/filings/0001558370-24-005600.md) | [482](/filings/0001558370-24-010481.md) | [483](/filings/0001558370-24-013951.md) | [484](/filings/0001558370-25-006002.md) | [485](/filings/0001558370-25-009801.md) | [486](/filings/0001104659-25-103732.md) | [484](/filings/0001104659-26-051518.md) | [482](/filings/0001104659-26-088150.md) | [482](/filings/0001104659-26-119634.md) | [478](/filings/0001104659-26-051518.md) | [477](/filings/0001104659-26-088150.md) | [477](/filings/0001104659-26-119634.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 472,346,000 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001104659-26-119634.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 05:24 ET. No prices; not investment advice.